This is the first study analyzing changes in fecal microbiota in dogs with skin allergies fed a diet based on hydrolyzed fish protein and rice starch.
4.1. General Pre-Diet Microbiota Findings: Do Dogs with Skin Allergies Have a Different Microbiota/Microbiome?
The main phyla of bacteria present in the fecal microbiota of our dogs is similar to what has been previously published:
Firmicutes,
Proteobacteria,
Fusobacteria and
Bacteroidetes are the four most represented phyla [
36]. Prevalence of each phylum in our study and in previously published works can be very variable. In his original report, Suchodolski reported the majority of
Firmicutes (47.7%), followed by
Proteobacteria (23.3%),
Fusobacteria (16.6%) and
Bacteroidetes (12.4%) [
36]. In our dogs, the microbiota in all dogs was dominated by
Bacteroidetes, with a percentage similar to what was described by Rostaher and coworkers [
19], albeit with higher levels of
Fusobacteria (mean 24.6%) and lower of
Firmicutes (mean 17.9%) and
Proteobacteria (mean 5.9%). Allaway and coworkers [
37], after feeding a complex commercial diet, reported a majority of
Bacteroides (55%), followed by 20%
Firmicutes, 10%
Fusobacteria and 10%
Proteobacteria, more in line with our results.
Due to the fact that only pruritic animals were sampled, and no healthy controls, we are not able to say if the microbiota in this population was different to that of healthy dogs. Rostaher and coworkers [
19] found no significant difference at the phylum level between atopic and normal dogs, while they reported the families of
Anaerovoracaceae,
Ruminococcaceae and
Peptostreptococcaceae to be significantly decreased in atopic versus healthy dogs. In our samples, the percentages of
Anaerovoracaceae and
Peptostreptococcaceae were similar to what was reported by Rostaher and coworkers in atopic dogs [
19], while
Ruminococcacee levels were higher in all our allergic dogs. At the genus level, Rostaher found
Catenibacterium to be increased in atopic dogs [
19]. This genus was observed, albeit in small amounts, in all our study groups, with an important decrease in post-diet samples.
More recently, Sikko et al. [
38] also compared the microbiota in healthy and atopic dogs, reporting an increase in
Escherichia-Shigella in atopic animals, suggesting that this increase could be the consequence of antibiotic use in allergic animals. Indeed, it is not always easy to determine if microbiota alterations in allergic dogs are the cause of the allergic condition or the consequence of the many medications these dogs receive for their dermatitis. Interestingly, in our study,
Escherichia-Shigella was particularly increased in CAD dogs only, with a decrease in post-diet samples, suggesting that a higher isolation of
Escherichia-Shigella in CAD dogs could be related to the atopic disease.
4.2. Comparison between Groups in Pre-Diet Samples: Can We Associate a Single Pathological State (e.g., Adverse Food Reaction, Canine Atopic Dermatitis) with Specific Signatures in the Gut Microbiome?
To the authors’ knowledge, this is the first time that microbiota is analyzed in food allergic dogs and compared to that of atopic ones. Different to what was described by Rostaher et al. [
19], who observed a significantly different bacterial alpha diversity between healthy and allergic dogs, no difference was observed in our study between groups. This could be due to the fact that all animals in our study were allergic, even if the Shannon diversity value reported by Rostaher and coworkers [
19] in their allergic dogs (about five) seems to be lower than what was observed in ours (about seven). Direct comparisons cannot be made, as the calculation methods and software may have been different.
No significant difference (beta diversity) was observed between groups in pre-diet samples. In general, atopic dogs showed lower amounts of phylum
Firmicutes and genus
Prevotella and higher amounts of phylum
Bacteroidetes and family
Bacteroides.
Firmicutes play a significant role in the relationship between gut bacteria and health. Many of the members of this phylum break down complex carbohydrates such as dietary fiber, which cannot be digested by the gut, and resistant starch, with production of short-chain fatty acids (SCFAs), including propionate, acetate and butyrate, which help prevent inflammation and improve colonocyte health [
13]. Different gut microbiome structures in allergic dogs may reflect an altered functional potential, because members of the gut microbiota can influence skin conditions through their metabolic activity and immunological impact [
15]. SCFAs derived from fiber through the gut can influence the prevalence of certain microbial groups, which subsequently affects cutaneous immune defense mechanisms. For example, some commensal gut microbes can control T cell differentiation, including T-regs, which contribute to the skin immune system. Disruption of gut integrity and an imbalance within microbial communities can have a significant impact on the overall skin homeostasis if resident T-regs become less abundant, so a decrease in fermenting
Firmicutes could possibly predispose dogs to developing a cutaneous allergic disease [
39].
In AFR dogs, the gut microbiota contains more
Prevotella species.
Prevotella bacteria are able to break down a variety of polysaccharides, have the capacity to synthesize propionate and, conversely, lead to lower levels of butyrate. High levels of
Prevotella were detected in stool samples from patients with rheumatoid arthritis, IBD, obesity and diabetes [
40].
Prevotella copri revealed pathobiontic properties such as releasing inflammatory mediators from immune and stromal cells and promoting inflammatory diseases.
In this study, we also sought to identify specific microbiota signatures in the various groups of dogs that could explain the different responses to the diet and thus the final diagnosis (AFR vs. CAD), allowing a prediction of the response to the diet based on baseline signatures and clinical characteristics [
41]. Only pre-diet AFR dogs showed a microbiota deficient in genus
Paraacteroides bacteria, with an increase after the diet.
Parabacteroides consists of Gram-negative, obligate anaerobes. At present, the link between
Paraacteroides deficiency and skin allergies has not yet been identified, although in a recent study,
P. distasonis presence was found to be significantly decreased in psoriatic patients, compared to non-psoriatic patients [
42]. More patients probably need to be analyzed to obtain statistically significant results in the determination of microbiota signatures in allergic dogs.
4.3. Response to the Diet and Impact on Metabolic Pathways: Is FUH Able to Improve Microbiota Alterations in Skin Allergic Dogs?
The carbohydrate source of FUH is rice starch (RS). RS, a dietary fiber, has been documented to offer numerous health advantages, notably in lowering the risk of chronic diseases like obesity and diabetes. These favorable impacts can be attributed to alterations in the gut bacteria population and the production of microbial-generated metabolites, such as short-chain fatty acids (SCFAs), particularly butyrate and acetate [
43]. Colonocytes primarily utilize butyrate as their primary energy source, while acetate and propionate are transported to the liver through the portal vein. In the liver, propionate is metabolized for gluconeogenesis, while acetate serves as a substrate for cholesterol synthesis and lipogenesis. Additionally, acetate is taken up by muscle and adipose tissue. Our study revealed that a diet high in RS resulted in increased production of SCFA-producing bacteria, such as
Bacteroides, in the luminal content. However, this effect was observed only in AFR and D dogs.
In the diet fed, Farmina Ultra Hypo, the protein source is hydrolyzed fish, composed of small peptides or single amino acids that decrease the probability of an immune response to protein dietary components. In spite of feeding an 8-week course of a hydrolyzed-protein-based diet exclusively, the bacterial diversity did not seem to be affected, as no significant variation in the Shannon index was observed. A similar result was obtained in other studies in which hydrolyzed protein/crystallized amino acid and starch diets were fed to healthy dogs for at least 4 weeks [
26,
31].
On the contrary, analysis of microbiota differences (beta diversity) between pre-and post-diet samples found significant differences for the AFR and CAD groups. In post-diet samples in all groups, there was a decrease in the phylum Bacteroidetes, and the reduction was driven by the group of Bacteroides. Bacteria in the phylum Firmicutes increased significantly only in CAD dogs, while Proteobacteria, family Enterobacteriaceae were reduced (p-value 0.22).
In a previous study in which dogs were fed a similar hydrolyzed proteins/starch diet to healthy dogs, changes obtained were partly similar to ours: a decrease in
Bacteroidetes and an increase in
Fusobacteria were reported, while
Firmicutes were unchanged and
Proteobacteria were decreased [
31]. At the family level, the same study reported an increase in Bacteroidacee and a decrease in
Prevotellacee. This pattern was also observed in our dogs, with the exception of CAD dogs, in which this pattern was reversed.
At the genus level, only AFR and D dogs showed a high
Prevotella/
Bacteroides ratio, which decreased substantially with the diet, with
Prevotella decreasing and
Bacteroides and
Fusobacteria increasing in both groups.
Bacteroides is known for its exceptional capacity to digest carbohydrates and its remarkable adaptability to swiftly changing environments. The rise in
Bacteroides levels is primarily responsible for the reduction in species richness and diversity, as well as the enrichment of glycolytic metabolism that has been observed [
44].
The abovementioned Prevotella/Bacteroides ratio was very different in the CAD group, where the ratio was already low at the beginning due to very high Bacteroides levels (double the other groups) and lower Prevotella (less than half of the other groups), and the ratio was only minimally increased with the diet.
The ratio of
Bacteroides +
Prevotella/
Fusobacteria, which is considered relevant for a healthy canine gut [
35], decreased importantly in all groups. However, CAD dogs seem to have a different microbiota pattern and different responses when compared to AFR and D dogs, because at the genus level,
Bacteroides increase in AFR and D dogs, while they decrease in CAD dogs.
Interestingly, a completely different pattern was observed in the microbiota of dogs fed another hydrolyzed feather/corn starch diet (Royal Canin Anallergenic
®) by Mori and coworkers [
26], who observed very high amounts of
Firmicutes (mean 71.7%), much higher than
Bacteroidetes (23.9%), and extremely low amounts of
Fusobacteria (0.4%). This difference could be driven by a different dietary composition, in particular by higher carbohydrates and fiber in the diet used in the abovementioned study.
Indeed, the main changes in the microbiota after a dietary trial depend on the amount of proteins, fats, carbohydrates and fibers present in the diet. As mentioned before,
Firmicutes favor high fiber and carbohydrate content [
27]; among them, there are
Lactobacilla and other beneficial bacteria that produce butyrate, in particular
Faecalibacterium,
Eubacterium,
Roseburia and
Anaerostipes. Butyrate offers numerous health benefits due to its multiple functions: it serves as an energy source for the cells lining the gut, stimulates the production of glutathione (a natural antioxidant), regulates intestinal inflammation and promotes a resilient gut lining. Additionally, it plays a role in enhancing the memory potential of activated CD8+ T cells by influencing their cellular metabolism. Moreover, butyrate aids in the prevention of cancer by impeding the development of neoplastic cells and supports the production of hormones for a healthy metabolism [
45].
Firmicutes were particularly enriched in the AFR group of dogs, among these Roseburia, known to produce butyrate that, together with the short-chain fatty acids of the fish oil added to FUH, has the potential to improve the defense barrier of the intestinal lining, including tight junctions.
Fusobacteria are known to be increased in dogs fed raw meat [
27], which is low in carbohydrates and fiber. Interestingly,
Fusobacteria levels were much higher in pre-diet AFR and D samples compared to CAD dogs. Due to an unknown previous dietary history, it is not known if one or more dogs in the former two groups were eating BARF diets and thus could have skewed the data. In any case, the higher amount of
Fusobacteria remained unchanged during the study, after feeding the commercial diet containing both carbohydrates and fiber.
Fusobacterium abundance is increased in dogs with access to the outdoors, and higher levels of
Fusobacterium are also seen in other carnivore species [
13].
4.4. CAD Dogs Are Different: Are Microbiota/Microbiome Alterations Significant in Dogs That Do Not Improve on the Diet?
We have already described in the paragraphs above how in many aspects CAD dogs show several differences to AFR and D dogs, and how D dogs seem to be more similar to AFR than CAD dogs. It may be that D dogs were not challenged for long enough or with the correct offending food to show a relapse and be categorized in the AFR group.
On the other hand, CAD dogs presented a different microbiome pattern before the diet and showed a different change dynamic and no enrichment after the diet, but on the contrary, useful Firmicutes like Lactobacillus and Collinsella decreased compared to the other groups.
Microbiota enrichment is key for improvement of atopic disease at the skin level, and it is possible that this is true for the gut microbiota too [
46]. CAD dogs could thus benefit from probiotics to improve their cutaneous disease, as has already been suggested by early studies performed by Marsella et al. [
24,
25].
Atopic dermatitis (AD) in humans is a chronic inflammatory skin condition with a multifactorial pathogenesis. Inflammatory bowel disease (IBD) can be accompanied by skin lesions [
47]. It has been suggested that skin conditions associated with IBD may stem from immune dysregulation, leading to a destructive process mediated by lymphocytes [
48]. T cells present in the gut mucosa may migrate to the skin, become exposed to cutaneous antigens and contribute to skin damage [
49]. Emerging evidence supports the existence of a gut–skin axis, which is influenced by neuroendocrine molecules produced by the gut microbiome [
39]. These molecules have the potential to affect both skin barrier dysfunction and immune system dysregulation, which are key factors in the development of atopic dermatitis (AD).
In our study, we observed a deficiency of apelin in dogs with AD before the dietary intervention. Apelin acts as an endogenous ligand for the APJ receptor, a seven-transmembrane G-protein-coupled receptor. Apelin and APJ receptors are distributed in various tissues, including the heart, lungs, liver, kidney and gastrointestinal tract. Previous research has shown that apelin messenger RNA is widely expressed in gastrointestinal (GI) tissues, particularly in the stomach and small intestine, and is closely associated with GI function. Under normal conditions, the apelin/APJ system plays diverse biological roles, such as gastric acid secretion, appetite control, cell proliferation and apoptosis, CCK secretion, histamine release, pancreatic juice secretion, GI motility and gut–brain axis regulation. The apelin/APJ system also plays significant roles in pathological conditions, acting as a potential gastric injury protectant, a marker for gastric and colon cancer, a lipid regulator for nonalcoholic fatty liver disease (NAFLD) and a mediator of fibrosis. Recent animal studies have reported that an increased intake of fatty acids and eicosapentaenoic acid (EPA) leads to increased apelin expression and concentration [
48].
In dogs with canine atopic dermatitis (CAD), we observed a deficiency in glycosphingolipid pathways before the dietary intervention, which significantly improved following the diet. Recent research has proposed that sphingolipids and the enzymes involved in their metabolism may play a role in the development of allergic diseases. Sphingolipids are crucial for cell growth, survival, inflammation and tissue remodeling. Biologically, sphingolipids are primarily found in the plasma membrane, intracellular organelles and lipoproteins, acting as a reservoir of bioactive metabolites involved in signaling, cell survival and growth, immune cell trafficking and vascular and mucosal integrity [
50]. In areas affected by AD lesions, epidermal barrier dysfunction is evident, characterized by increased trans-epidermal water loss, elevated skin pH, altered surface microbiota colonization patterns and an affected ceramide profile. The compromised barrier function in AD leads to the continuous generation of cytokines, chemokines, proinflammatory cytokine cascades, and exposure to allergens and antigens, all of which contribute to the “atopic march.” The reduction or alteration of sphingolipid composition in the epidermis not only contributes to impaired skin barrier function but also promotes the development of inflammatory and allergic properties in individuals with AD [
48].
While the majority of bacterial species lack the ability to produce sphingolipids,
Bacteroides, a prominent commensal microbiome in the intestine, possesses the capability to produce and supply ceramides. These ceramides play a role in dampening inflammatory responses and contributing to the maintenance of intestinal immune system homeostasis. On the other hand, host-derived sphingolipids from the intestine aid in preserving
Bacteroides species or regulating their abundance through the bactericidal activity of sphingosine. In contrast, the uncontrolled proliferation of pathogenic bacteria like
Pseudomonas,
Staphylococcus or
Mycobacterium can disrupt the balance of the bacterial flora and hinder host sphingolipid metabolism [
51]. In our study, post-dietary intervention, we observed an increase in
Bacteroides species in AFR and D dogs, while CAD dogs showed a reduction in
Bacteroides levels.
4.5. AFR Dogs and D Dogs: Are Microbiota/Microbiome Alterations Significant in Dogs That Do Improve on the Diet?
In AFR dogs, there is a post-diet increase in the glycolysis metabolic pathway from fructose and an enrichment of Bacilli, Roseburia, Parabacteroides, Lachnospira, Erysipelatoclostridum, Clostridium UCG 14 and bacteria of Vampirivibrio class.
Fructolysis, a process similar to glycolysis, utilizes many of the same enzymes and metabolic intermediates. However, fructose differs in that it enters glycolysis without the energy investment step, resulting in an additional ATP yield. Unlike glucose, which undergoes metabolism throughout the body, fructose is primarily metabolized in the liver. Its metabolism in the liver primarily contributes to replenishing liver glycogen and synthesizing triglycerides. Fructose facilitates the uptake and storage of glucose in the liver, accelerates the oxidation of carbohydrate stores after a meal, supplies the majority of energy required for spermatozoa mobility and potentially plays a crucial role in the maturation of preadipocytes, enabling them to store more fat. Furthermore, fructose may benefit individuals involved in intense physical activity by supporting hepatic gluconeogenesis and providing additional energy for skeletal muscle contraction in the form of lactate [
52].
Our metagenomics study suggests that dogs in the AFR group have, after being fed the FUH diet, an increased ability to utilize sugars using an improved metabolic pathway and that the organic components of the diet provide a favorable substrate for the growth of butyrate- and acetate-producing bacteria. One possibility is that the metabolism of fructose may confer a greater advantage for Bacilli and intestinal butyrate–acetate producing bacteria. Indeed, microbes depend on their community to support all biological activities essential for their metabolism.
Also, in the group of doubtful dogs, even if it was much lower, an increase in species Anaerofilus, belonging to the Lachnospiranacee family, was observed, with genes related to acetogenesis, capable of reducing fructose to acetate.